Loncar China BioPharma ETF - Distributing - USD Stock

ETF

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-8.08%	-27.92%

Duration

Period

Style

The Loncar China BioPharma ETF (the Fund) seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the Index).

Name	Price	Change	5d. change	1st Jan change	Weight
LEGEND BIOTECH CORPORATION	44.74 USD	-2.78%	+2.80%	-25.64%	3.08%
SINOPHARM GROUP CO. LTD.	20.9 HKD	+0.48%	0.00%	+2.20%	2.58%
BEIGENE, LTD.	143.9 USD	-0.66%	-4.68%	-20.20%	2.48%
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.	32.5 HKD	+1.25%	+4.50%	+12.90%	2.24%
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.	20.75 HKD	0.00%	-0.24%	-4.60%	2.09%
WUXI BIOLOGICS (CAYMAN) INC.	11.34 HKD	+1.43%	-7.05%	-61.69%	2.09%
CSPC PHARMACEUTICAL GROUP LTD.	6.2 HKD	-0.80%	-5.34%	-14.60%	2.02%

Vanguard FTSE Asia Ex Japan Shares Index ETF Announces Quarterly Cash Distribution for the Period Ending 30 June 2024	Jul. 02	CI
Vanguard Australian Shares High Yield ETF Announces Quarterly Cash Distribution for the Period Ended 30 June 2024	Jul. 02	CI
Vanguard Australian Property Securities Index ETF Announces Quarterly Distribution for the Period Ending 30 June 2024	Jul. 02	CI
A patriotic ETF	Jul. 01	MT
ETFs beating markets without Nvidia	Jul. 01	MT
BlackRock launches stock ETF with 100% downside hedge	Jul. 01	RE
BlackRock launches stock ETF with 100% downside hedge	Jul. 01	RE
BlackRock teases indexes for private markets after Preqin deal	Jul. 01	RE

In partnership with

	US26922A3703
Total Expense Ratio	0.79%
Asset Class	Actions
Sector	No restriction
Size	No restriction
Currency	USD
Provider	Exchange Traded Concepts
Underlying	Loncar China BioPharma Index - USD

Retail investor